APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Abuse Treatment

Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

Selected research

Market Analysis & Forecast

Global Drug Abuse Treatment Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchDrug Abuse Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Abuse Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Drug Abuse Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Abuse Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Abuse Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.

North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Drug Abuse Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Abuse Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Abuse Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Abuse Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Abuse Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Abuse Treatment revenue, projected growth trends, production technology, application and end-user industry.

Drug Abuse Treatment Segment by Company

Indivior

Pfizer

Alkermes

Novartis

Mylan

Cipla

Glenmark

Dr. Reddy's Laboratories

Teva Pharmaceutical

PLIVA (Odyssey)

Drug Abuse Treatment Segment by Type

Opioid Addiction

Tobacco/Nicotine Addiction

Alcohol Dependence

Drug Abuse Treatment Segment by Application

Hospital & Clinics

Residential (non-hospital)

Drug Abuse Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Abuse Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Abuse Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Abuse Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Abuse Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Abuse Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Abuse Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Abuse Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Opioid Addiction Major Player Table 3. Tobacco/Nicotine Addiction Major Player Table 4. Alcohol Dependence Major Player Table 5. Global Drug Abuse Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital & Clinics Major Player Table 7. Residential (non-hospital) Major Player Table 8. Drug Abuse Treatment Industry Trends Table 9. Drug Abuse Treatment Industry Drivers Table 10. Drug Abuse Treatment Industry Opportunities and Challenges Table 11. Drug Abuse Treatment Industry Restraints Table 12. Global Drug Abuse Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Drug Abuse Treatment Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Drug Abuse Treatment Market Share by Region (2021-2026) Table 15. Global Drug Abuse Treatment Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Drug Abuse Treatment Market Share by Region (2027-2032) Table 17. Global Drug Abuse Treatment Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Drug Abuse Treatment Revenue Market Share by Players (2021-2026) Table 19. Global Drug Abuse Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Drug Abuse Treatment Key Players Headquarters & Area Served Table 21. Global Drug Abuse Treatment Players, Product Type & Application Table 22. Global Drug Abuse Treatment Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Drug Abuse Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Drug Abuse Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drug Abuse Treatment Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Drug Abuse Treatment Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Drug Abuse Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Drug Abuse Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Drug Abuse Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Drug Abuse Treatment Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Drug Abuse Treatment Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Drug Abuse Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Drug Abuse Treatment Revenue Market Share by Application (2027-2032) Table 35. Indivior Company Information Table 36. Indivior Business Overview Table 37. Indivior Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Indivior Drug Abuse Treatment Product Portfolio Table 39. Indivior Recent Development Table 40. Pfizer Company Information Table 41. Pfizer Business Overview Table 42. Pfizer Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer Drug Abuse Treatment Product Portfolio Table 44. Pfizer Recent Development Table 45. Alkermes Company Information Table 46. Alkermes Business Overview Table 47. Alkermes Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Alkermes Drug Abuse Treatment Product Portfolio Table 49. Alkermes Recent Development Table 50. Novartis Company Information Table 51. Novartis Business Overview Table 52. Novartis Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Novartis Drug Abuse Treatment Product Portfolio Table 54. Novartis Recent Development Table 55. Mylan Company Information Table 56. Mylan Business Overview Table 57. Mylan Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Mylan Drug Abuse Treatment Product Portfolio Table 59. Mylan Recent Development Table 60. Cipla Company Information Table 61. Cipla Business Overview Table 62. Cipla Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Cipla Drug Abuse Treatment Product Portfolio Table 64. Cipla Recent Development Table 65. Glenmark Company Information Table 66. Glenmark Business Overview Table 67. Glenmark Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Glenmark Drug Abuse Treatment Product Portfolio Table 69. Glenmark Recent Development Table 70. Dr. Reddy's Laboratories Company Information Table 71. Dr. Reddy's Laboratories Business Overview Table 72. Dr. Reddy's Laboratories Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Dr. Reddy's Laboratories Drug Abuse Treatment Product Portfolio Table 74. Dr. Reddy's Laboratories Recent Development Table 75. Teva Pharmaceutical Company Information Table 76. Teva Pharmaceutical Business Overview Table 77. Teva Pharmaceutical Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Teva Pharmaceutical Drug Abuse Treatment Product Portfolio Table 79. Teva Pharmaceutical Recent Development Table 80. PLIVA (Odyssey) Company Information Table 81. PLIVA (Odyssey) Business Overview Table 82. PLIVA (Odyssey) Drug Abuse Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. PLIVA (Odyssey) Drug Abuse Treatment Product Portfolio Table 84. PLIVA (Odyssey) Recent Development Table 85. North America Drug Abuse Treatment Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Drug Abuse Treatment Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Drug Abuse Treatment Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Drug Abuse Treatment Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Drug Abuse Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Drug Abuse Treatment Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Drug Abuse Treatment Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Drug Abuse Treatment Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Drug Abuse Treatment Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Drug Abuse Treatment Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Drug Abuse Treatment Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Drug Abuse Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Drug Abuse Treatment Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Drug Abuse Treatment Revenue by Country (US$ Million) & (2027-2032) Table 99. China Drug Abuse Treatment Revenue by Type (2021-2026) & (US$ Million) Table 100. China Drug Abuse Treatment Revenue by Type (2027-2032) & (US$ Million) Table 101. China Drug Abuse Treatment Revenue by Application (2021-2026) & (US$ Million) Table 102. China Drug Abuse Treatment Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Drug Abuse Treatment Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Drug Abuse Treatment Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Drug Abuse Treatment Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Drug Abuse Treatment Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Drug Abuse Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Drug Abuse Treatment Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Drug Abuse Treatment Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Drug Abuse Treatment Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Drug Abuse Treatment Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Drug Abuse Treatment Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Drug Abuse Treatment Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Drug Abuse Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Drug Abuse Treatment Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Drug Abuse Treatment Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Drug Abuse Treatment Image Figure 2. Global Drug Abuse Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Abuse Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Opioid Addiction Image Figure 5. Tobacco/Nicotine Addiction Image Figure 6. Alcohol Dependence Image Figure 7. Global Drug Abuse Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Drug Abuse Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital & Clinics Image Figure 10. Residential (non-hospital) Image Figure 11. Global Drug Abuse Treatment Market Size (US$ Million) & (2021-2032) Figure 12. Global Drug Abuse Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Drug Abuse Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Drug Abuse Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Drug Abuse Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Drug Abuse Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Drug Abuse Treatment Revenue Market Share by Type (2021-2032) Figure 19. Global Drug Abuse Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drug Abuse Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Drug Abuse Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Drug Abuse Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Drug Abuse Treatment Revenue Share by Type (2021-2032) Figure 24. North America Drug Abuse Treatment Revenue Share by Application (2021-2032) Figure 25. North America Drug Abuse Treatment Revenue Share by Country (2021-2032) Figure 26. United States Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Drug Abuse Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Drug Abuse Treatment Revenue Share by Type (2021-2032) Figure 31. Europe Drug Abuse Treatment Revenue Share by Application (2021-2032) Figure 32. Europe Drug Abuse Treatment Revenue Share by Country (2021-2032) Figure 33. Germany Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Drug Abuse Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Drug Abuse Treatment Revenue Share by Type (2021-2032) Figure 43. China Drug Abuse Treatment Revenue Share by Application (2021-2032) Figure 44. Asia Drug Abuse Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Drug Abuse Treatment Revenue Share by Type (2021-2032) Figure 46. Asia Drug Abuse Treatment Revenue Share by Application (2021-2032) Figure 47. Asia Drug Abuse Treatment Revenue Share by Region (2021-2032) Figure 48. Japan Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Drug Abuse Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Drug Abuse Treatment Revenue Share by Type (2021-2032) Figure 56. SAMEA Drug Abuse Treatment Revenue Share by Application (2021-2032) Figure 57. SAMEA Drug Abuse Treatment Revenue Share by Country (2021-2032) Figure 58. Brazil Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Drug Abuse Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Opioid Addiction
  • Tobacco/Nicotine Addiction
  • Alcohol Dependence
Applications
  • Hospital & Clinics
  • Residential (non-hospital)
Companies covered
  • Indivior
  • Pfizer
  • Alkermes
  • Novartis
  • Mylan
  • Cipla
  • Glenmark
  • Dr. Reddy's Laboratories
  • Teva Pharmaceutical
  • PLIVA (Odyssey)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Abuse Treatment Market by Type
  3. 1.2.1 Global Drug Abuse Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Opioid Addiction
  5. 1.2.3 Tobacco/Nicotine Addiction
  6. 1.2.4 Alcohol Dependence
  7. 1.3 Drug Abuse Treatment Market by Application
  8. 1.3.1 Global Drug Abuse Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital & Clinics
  10. 1.3.3 Residential (non-hospital)
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Drug Abuse Treatment Market Dynamics
  1. 2.1 Drug Abuse Treatment Industry Trends
  2. 2.2 Drug Abuse Treatment Industry Drivers
  3. 2.3 Drug Abuse Treatment Industry Opportunities and Challenges
  4. 2.4 Drug Abuse Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Abuse Treatment Market Perspective (2021-2032)
  2. 3.2 Global Drug Abuse Treatment Growth Trends by Region
  3. 3.2.1 Global Drug Abuse Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Abuse Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Abuse Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Abuse Treatment Revenue by Players
  2. 4.1.1 Global Drug Abuse Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Abuse Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Abuse Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Abuse Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Abuse Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Drug Abuse Treatment Players, Product Type & Application
  8. 4.5 Global Drug Abuse Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Abuse Treatment Market CR5 and HHI
  11. 4.6.3 2025 Drug Abuse Treatment Tier 1, Tier 2, and Tier 3
5 Drug Abuse Treatment Market Size by Type
  1. 5.1 Global Drug Abuse Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Abuse Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Drug Abuse Treatment Revenue Market Share by Type (2021-2032)
6 Drug Abuse Treatment Market Size by Application
  1. 6.1 Global Drug Abuse Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Abuse Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Drug Abuse Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Indivior
  2. 7.1.1 Indivior Company Information
  3. 7.1.2 Indivior Business Overview
  4. 7.1.3 Indivior Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Indivior Drug Abuse Treatment Product Portfolio
  6. 7.1.5 Indivior Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Drug Abuse Treatment Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Alkermes
  14. 7.3.1 Alkermes Company Information
  15. 7.3.2 Alkermes Business Overview
  16. 7.3.3 Alkermes Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Alkermes Drug Abuse Treatment Product Portfolio
  18. 7.3.5 Alkermes Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Drug Abuse Treatment Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Drug Abuse Treatment Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Cipla
  32. 7.6.1 Cipla Company Information
  33. 7.6.2 Cipla Business Overview
  34. 7.6.3 Cipla Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cipla Drug Abuse Treatment Product Portfolio
  36. 7.6.5 Cipla Recent Developments
  37. 7.7 Glenmark
  38. 7.7.1 Glenmark Company Information
  39. 7.7.2 Glenmark Business Overview
  40. 7.7.3 Glenmark Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Glenmark Drug Abuse Treatment Product Portfolio
  42. 7.7.5 Glenmark Recent Developments
  43. 7.8 Dr. Reddy's Laboratories
  44. 7.8.1 Dr. Reddy's Laboratories Company Information
  45. 7.8.2 Dr. Reddy's Laboratories Business Overview
  46. 7.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Dr. Reddy's Laboratories Drug Abuse Treatment Product Portfolio
  48. 7.8.5 Dr. Reddy's Laboratories Recent Developments
  49. 7.9 Teva Pharmaceutical
  50. 7.9.1 Teva Pharmaceutical Company Information
  51. 7.9.2 Teva Pharmaceutical Business Overview
  52. 7.9.3 Teva Pharmaceutical Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Teva Pharmaceutical Drug Abuse Treatment Product Portfolio
  54. 7.9.5 Teva Pharmaceutical Recent Developments
  55. 7.10 PLIVA (Odyssey)
  56. 7.10.1 PLIVA (Odyssey) Company Information
  57. 7.10.2 PLIVA (Odyssey) Business Overview
  58. 7.10.3 PLIVA (Odyssey) Drug Abuse Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 PLIVA (Odyssey) Drug Abuse Treatment Product Portfolio
  60. 7.10.5 PLIVA (Odyssey) Recent Developments
8 North America
  1. 8.1 North America Drug Abuse Treatment Revenue (2021-2032)
  2. 8.2 North America Drug Abuse Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Abuse Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Abuse Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Drug Abuse Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Abuse Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Abuse Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Abuse Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Drug Abuse Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Abuse Treatment Revenue by Country
  11. 8.6.1 North America Drug Abuse Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Abuse Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Abuse Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Abuse Treatment Revenue (2021-2032)
  2. 9.2 Europe Drug Abuse Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Abuse Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Abuse Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Abuse Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Abuse Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Abuse Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Abuse Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Abuse Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Abuse Treatment Revenue by Country
  11. 9.6.1 Europe Drug Abuse Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Abuse Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Abuse Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Abuse Treatment Revenue (2021-2032)
  2. 10.2 China Drug Abuse Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Abuse Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Abuse Treatment Revenue by Type (2027-2032)
  5. 10.3 China Drug Abuse Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Abuse Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Abuse Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Abuse Treatment Revenue by Application (2027-2032)
  9. 10.5 China Drug Abuse Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Abuse Treatment Revenue (2021-2032)
  2. 11.2 Asia Drug Abuse Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Abuse Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Abuse Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Abuse Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Abuse Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Abuse Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Abuse Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Abuse Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Abuse Treatment Revenue by Country
  11. 11.6.1 Asia Drug Abuse Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Abuse Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Abuse Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Abuse Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Drug Abuse Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Abuse Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Abuse Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Abuse Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Abuse Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Abuse Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Abuse Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Abuse Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Abuse Treatment Revenue by Country
  11. 12.6.1 SAMEA Drug Abuse Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Abuse Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Abuse Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst